Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
All
13F
13D/G
Other
Tags
CC transcript
GSK plc (GSK)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
01/27/2021
GN
Lilly, Vir Biotechnology and GSK Announce First Patient Dosed in Expanded BLAZE-4 Trial Evaluating Bamlanivimab (LY-CoV555) with VIR-7831 (GSK4182136) for COVID-19
01/12/2021
GN
Vir Biotechnology and GSK Announce NHS-Supported AGILE Study to Evaluate VIR-7832 in the Early Treatment of COVID-19
10/06/2020
GN
Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study evaluating VIR-7831 for the treatment of COVID-19
09/08/2020
GN
Biopharma Leaders Unite to Stand with Science
08/31/2020
GN
Vir Biotechnology and GSK Start Phase 2/3 Study of COVID-19 Antibody Treatment
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy